On Thursday, Shares of CMS Energy Corporation (NYSE:CMS), lost -1.24% to $32.70.
CMS Energy, declared stated net income of $67 million, or $0.25 per share, for the second quarter of 2015 and $269 million, or $0.98 per share, for the first half of 2015. Adjusted (non-Generally Accepted Accounting Principles) earnings per share for the second quarter and first half were the same as stated amounts. Earnings per share in 2015 grew 3 cents contrast with 2014 on a weather-normalized basis.
CMS Energy reaffirmed its guidance for 2015 adjusted earnings of $1.86 to $1.89 per share. This is compriseent with the company’s long-term plan of 5 percent to 7 percent annual adjusted earnings per share growth.
CMS Energy Corporation operates as an energy company primarily in Michigan, the United States. The company’s Electric Utility segment engages in the generation, purchase, distribution, and sale of electricity to residential, commercial, and various industrial customers in Michigan’s Lower Peninsula. It operates a network of coal, gas, hydroelectric, oil, and wind generation plants.
Shares of Scorpio Bulkers Inc (NYSE:SALT), declined -1.65% to $1.79, during its last trading session.
Scorpio Bulkers, declared that the Company plans to issue its second quarter 2015 earnings before the market open on Tuesday, July 28, 2015 and will host a conference call later in the day at 11:00 AM Eastern Daylight Time and 5:00 PM Central European Summer Time.
Tuesday, July 28, 2015 at 11:00 AM Eastern Daylight Time and 5:00 PM Central European Summer Time.
Scorpio Bulkers Inc., together with its auxiliaries, engages in the marine transportation of dry bulk commodities. Its fleet transports a range of major and minor bulk commodities, counting ores, coal, grains, and fertilizers along worldwide shipping routes.
At the end of Thursday’s trade, Shares of Citizens Financial Group Inc (NYSE:CFG), lost -2.18% to $26.45.
Citizens Financial Group, reported second quarter net income of $190 million, or $0.35 per diluted common share, contrast with second quarter 2014 net income of $313 million, or $0.56 per diluted common share. The second quarter of 2014 comprised of the benefit of a $180 million after-tax gain related to the Chicago Divestiture. Second quarter 2015 net income was down $19 million from first quarter 2015 net income of $209 million, and diluted EPS was down $0.03 from $0.38 in first quarter 2015. Second quarter 2015 results were reduced by $25 million after-tax, or $0.05 per diluted common share, related to net restructuring charges and special items, as compared to $6 million after-tax, or $0.01, in first quarter 2015, and a net $0.19 benefit in the second quarter 2014, as detailed in the discussion of Results portion of this release. Second quarter 2015 Adjusted diluted EPS* of $0.40 compares with $0.39 in first quarter 2015 and $0.37 in second quarter 2014 given the impact of revenue growth initiatives, strong expense control, and continued favorable credit trends.
Bruce Van Saun, Chairman, & CEO commented, “We are happy with our ability to continue to execute well against the key initiatives in our turnaround plan. During the quarter, we demonstrated strong loan and deposit growth and good expense discipline, which combined for solid operating leverage, on an adjusted basis. We have launched a series of further initiatives which should continue to assist the trajectory of our financial performance.” Van Saun added, “We are on the right track. I feel good about the continued progress we are making.”
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United States.
Finally, Sequenom, Inc. (NASDAQ:SQNM), ended its last trade with 4.03% gain, and closed at $3.10.
Sequenom, declared it will report financial results for the second quarter 2015 after closing of the NASDAQ Global Market on Wednesday, August 5, 2015.
A conference call hosted by William Welch, CEO, and other members of senior administration will take place on Wednesday, August 5, 2015, at 5:00 p.m. EDT (2:00 p.m. PDT).
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
